Pacific Biosciences Of California reported $32.31M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Accelerate Diagnostics AXDX:US USD 2.96M 901K
Agilent A:US USD 1.85B 131M
Bruker BRKR:US USD 638.9M 50.5M
Danaher DHR:US USD 7.66B 88M
Fluidigm FLDM:US USD 25.65M 6.87M
General Electric GE:US USD 19.08B 439M
Illumina ILMN:US USD 1.12B 47M
Myriad Genetics MYGN:US USD 156.4M 22.9M
Nanostring Technologies NSTG:US USD 29.54M 2.68M
Pacific Biosciences Of California PACB:US USD 32.31M 3.16M
Perkinelmer PKI:US USD 711.8M 517.77M
Quidel QDEL:US USD 783.8M 170.4M
Roche Holding ROG:VX CHF 14.74B 1.7B
Thermo Fisher Scientific TMO:US USD 10.68B 293M
Waters WAT:US USD 708.56M 5.76M